Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$209.36 USD

209.36
424,614

-1.69 (-0.80%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $209.32 -0.04 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (49 out of 251)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Reasons to Retain Inspire Medical (INSP) Stock for Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Inspire Medical (INSP) Q3 Earnings Top Estimates, Revenues Lag

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the third quarter.

Charles River (CRL) to Report Q3 Earnings: What's in Store?

Charles River's (CRL) CRADLE initiative and research models in North America and China are anticipated to have maintained their growth momentum in the third quarter.

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Penumbra (PEN) to Report Q3 Earnings: What's in the Cards?

Penumbra (PEN) will likely report strong Neuro sales growth on the strength of its RED 72 (with the proprietary SENDit technology), RED 43 and BMX81.

What's in Store for Boston Scientific (BSX) in Q3 Earnings?

With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.

What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?

Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform.

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

Style Box ETF report for VTWO

Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

Style Box ETF report for VTWG

Inspire Medical (INSP) Q2 Earnings & Revenues Top Estimates

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.

Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 19.61% and 9.76%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

MedTech Stocks to Watch for Earnings on Aug 1: ECL, NVRO, INSP

MedTech companies' Q2 results are likely to reflect strength in customer demand. Let's see how ECL, NVRO and INSP are placed ahead of their earnings releases.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

Style Box ETF report for VTWO

Inspire Medical (INSP) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Inspire Medical's (INSP) global presence.

Inspire (INSP) Gets FDA Nod for Expanded Indication of AHI

The FDA approves Inspire's (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.

Syneos Health (SYNH) Down 0.1% Since Last Earnings Report: Can It Rebound?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Inspire (INSP) Up 6.3% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio

Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.

Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?

Style Box ETF report for VTWO

Inspire Medical (INSP) Q1 Earnings & Revenues Top Estimates

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 24.29% and 6.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. (HIMS) Surges 10.3%: Is This an Indication of Further Gains?

Hims & Hers Health, Inc. (HIMS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.